Cambridge, MA, United States of America

Noah Gardner

USPTO Granted Patents = 1 

 

Average Co-Inventor Count = 4.0

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2019

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Innovations by Noah Gardner in Nucleic Acid Encapsulation

Introduction

Noah Gardner is an innovative inventor based in Cambridge, MA (US). He has made significant contributions to the field of biotechnology, particularly in the encapsulation of nucleic acids. His work focuses on improving the delivery mechanisms of genetic materials, which has implications for various medical applications.

Latest Patents

Noah Gardner holds a patent for a method of encapsulating a nucleic acid in a lipid nanoparticle host. This patent describes a process where encapsulated nucleic acid nanoparticles of uniformly small particle size are produced by intersecting one or more nucleic acid streams with one or more lipid streams. The resulting nanoparticles include a nucleic acid encapsulated within a lipid nanoparticle host. Uniformly small particle sizes are achieved by intersecting an aqueous nucleic acid stream and a stream of lipids in organic solvent at high linear velocities, with total organic solvent concentrations less than 33%. This innovation is crucial for enhancing the efficacy of nucleic acid delivery systems.

Career Highlights

Noah Gardner is currently associated with Novartis AG, a leading global healthcare company. His role at Novartis allows him to collaborate with other experts in the field and contribute to groundbreaking research and development projects. His work has the potential to advance therapeutic strategies and improve patient outcomes.

Collaborations

Noah collaborates with talented individuals such as Keith Bowman and Travis Jeannotte. These partnerships foster a creative environment that encourages the exchange of ideas and enhances the development of innovative solutions in biotechnology.

Conclusion

Noah Gardner's contributions to the field of nucleic acid encapsulation represent a significant advancement in biotechnology. His innovative methods and collaborations with industry experts position him as a key player in the ongoing evolution of genetic material delivery systems.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…